The interaction potential of proton pump inhibitors;Das interaktionspotential der protonenpumpeninhibitoren

Verdauungskrankheiten

Volumn 20, Issue 1, 2002, Pages 26-31

  Klotz, U ^a  

^a Dr M F B Inst Klin Pharmakol   (Germany)

Author keywords

Drug interactions; Drug metabolism; Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Proton pump inhibitors; Rabeprazole

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

DOSE RESPONSE; DRUG ABSORPTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG POTENCY; ENZYME INHIBITION; HUMAN; PHARMACODYNAMICS; REVIEW; STOMACH DISEASE; STOMACH PH;

EID: 0036175188     PISSN: 0174738X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes
2. Drug interaction studies with esomeprazole, the (S)-enantiomer of omeprazole
3. Selection of drugs to treat gastro-oesophageal reflux disease. The role of drug interactions
4. Inhibition by omeprazole of proguanil metabolism: Mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments
5. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans
6. Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole
7. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice
8. Therapy of Helicobacter pylori: Current status and issues
9. Effect of omeprazole on concentration of clarithromycin in plasma and gastric juice at steady state
10. Pantoprazole lacks interaction with the NSAID piroxicam in man
11. Lack of interaction between pantoprazole and ethanol
12. Drug-drug interaction evaluation of rabeprazole sodium: A clean/expected slate?
13. Coadministration of rabeprazole sodium (E 3810) does not effect the pharmacokinetics of anhydrous theophylline or warfarin
14. Review article: Cytochrome P450 and the metabolism of proton pump inhibitors - Emphasis on rabeprazole
15. Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers
16. Pharmacokinetic considerations in the eradication of Helicobacter pylori
17. Similarities and differences in the properties of substituted benzimidazoles: A comparison between pantoprazole and related compounds
18. The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients
19. Species comparison in P450 induction: Effects of dexamethasone, omeprazole, and rifampicin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog
20. Induction of cytochrome P 450 IA genes (CYP1A) by omeprazole in the human alimentary tract
21. Interaction of proton pump inhibitors with cytochromes P450: Consequences for drug interactions
22. Comparative effects of rabeprazole and omeprazole on the inducibility of cytochrome P 450-3A isoenzymcs in human hepatocytes, and effects on cyclosporin metabolism in human liver microsomes
23. Proton pump inhibitors and acid-related diseases
24. Pantoprazole lacks interaction with the NSAID naproxen
25. Review article: Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors
26. Lack of pantoprazole drug interactions in man: An updated review
27. Therapie der Helicobacter-pylori-infektion
28. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate
29. The interaction of proton pump inhibitors with cytochromes P450
30. Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19